Published in

Wiley, Acta Neurologica Scandinavica, 4(138), p. 327-331, 2018

DOI: 10.1111/ane.12963

Links

Tools

Export citation

Search in Google Scholar

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO